Texas Oncology has been selected to participate in the Centers for Medicare and Medicaid Services (CMS) Oncology Care Model (OCM). The OCM is a new initiative introduced by CMS’ Innovation Center that will transform and enhance the delivery of cancer care. The OCM emphasizes overall quality, improved communications, and patient outcomes by supplementing the existing “fee for service” model to deliver and measure the value of the care received.
The OCM will bring changes to Texas Oncology’s treatment management and payment processes, along with enhancements that directly impact patients, including:
- Enhancing patient navigation services and follow-up after treatment
- Expanding survivorship and advance care planning programs
- Promoting awareness of 24/7 access to oncology teams
- Increasing shared decision making with a focus on patient education
The OCM program specifically applies to chemotherapy, hormonal, and immunotherapy treatments, but care for all patients will be enhanced through access to these additional services, regardless of treatment methods. The OCM is aligned with Texas Oncology’s patients-first, compassionate care approach and will result in greater collaboration among medical and radiation oncologists, and surgeons.
Texas Oncology’s commitment to evidenced-based care and value-based care models, like OCM, is ongoing and extensive. In its Pathways program, Texas Oncology uses evidenced-based best practices, based on the National Comprehensive Cancer Network, to provide high quality, effective treatment, minimizing side effects. Pathways guidelines prioritize improved patient outcomes, with consideration of value and side effects in determining appropriate treatment.
In addition, Texas Oncology has collaborated with health insurance providers, including Aetna and UnitedHealthcare on quality/value care models with similar objectives as the OCM, such as helping patients stay well during and after treatment, and avoid visits to the emergency room or hospital.
As a pioneer in community-based cancer care, Texas Oncology’s participation in the OCM is another example of our commitment to leadership and innovation in improving patient care.
Click to enlarge